VALEO MEDICAL
Valeo Medical, Inc., a life sciences company, develops a non-invasive diagnostic blood test for endometriosis. The company was founded in 2003 and is based in Burlington, Massachusetts. Valeo raised money as part of the Discovery Life Sciences fund which was partly funded by the Nashville Capital Network.
VALEO MEDICAL
Industry:
Biotechnology Health Care Life Science
Founded:
2003-01-01
Address:
Burlington, Massachusetts, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
7.95 M USD
Similar Organizations
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Investors List
Healthcare Capital Group
Healthcare Capital Group investment in Series B - Valeo Medical
Tullis Health Investors
Tullis Health Investors investment in Series B - Valeo Medical
Tullis Health Investors
Tullis Health Investors investment in Series A - Valeo Medical